Nucleosides and Nucleotides p. 31 - 45 (1996)
Update date:2022-07-29
Topics:
Shiragami, Hiroshi
Amino, Yusuke
Honda, Yutaka
Arai, Masayuki
Tanaka, Yasuhiro
Iwagami, Hisao
Yukawa, Toshihide
Izawa, Kunisuke
Practical method to produce 2′,3′-dideoxypurinenucleosides from 9-(2,5-di-O-acetyl-3-bromo-3-deoxy-β-D-xylofuranosyl)purines (1) was developed. High ratio of 2′,3′-dideoxynucleoside to 3′-deoxyribonucleoside was obtained by selecting the reaction conditions (solvent, pH and/or base), or changing 2′-acyloxy leaving group. The reaction mechanism was studied by deuteration experiments of 1a and 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-ribofuranosyl)thymine (12).
View MoreContact:+86-20-32051076
Address:1105,Building A, International Business Incubator,Science City
Shenzhen Sunrising Industry Co., ltd.
Contact:+86 755 86571158 / 86571159 / 86571160
Address:2108 ZHENYE INT. BUSINESS CENTER,NO.3101-90 QIANHAI RD, NANSHAN,SHENZHEN, CHINA
BrightGene Bio-Medical Technology Co., Ltd.
website:https://en.bright-gene.com/
Contact:+86-512-62551801
Address:Building C25 - C31, No. 218 Xinghu Road, Suzhou Industrial Park, Suzhou, Jiangsu, China.
ShangHai Soyoung Biotechnology Inc
website:http://www.soyoungbio.com
Contact:+86-21-69893009
Address:shanghai
Shandong Ailitong New Material Co.,Ltd
Contact:+86-536-3226266
Address:zhongjia village, putong town , qingzhou city,Shandong Province,China
Doi:10.1560/7J4F-D8BG-3FQR-E3TD
(2000)Doi:10.1016/S0960-894X(01)00254-2
(2001)Doi:10.1039/jr9440000338
(1944)Doi:10.1007/BF00477427
()Doi:10.1021/jo00799a032
(1972)Doi:10.1016/S0040-4039(01)00938-8
(2001)